Foresight Regulatory Strategy is a biotechnology company based out of 269 Ballardvale St, Wilmington, Massachusetts, United States.
| Website | http://www.frsi.net/ |
| Revenue | $4 million |
| Employees | 1 (0 on RocketReach) |
| Address | 187 Ballardvale St Ste A180, Wilmington, Massachusetts 01887, US |
| Phone | +1 978-658-6888 |
| Technologies | |
| Industry | Retail, Biotechnology Research |
| Keywords | Biotechnology, Regulatory, Strategy, Consulting, Compliance, Pharma, Clinical Trials, Government Affairs, Policy, Science, Healthcare, Fda, Drug Development, Medical Devices, Regulatory Affairs, Biopharma, Life Sciences, Risk Management, Legal, Research |
| Competitors | Regulatory Affairs Professionals Society (RAPS), Xcenda, Parexel, Celerion, Medpace, IQVIA, Veristat, Covance, The Weinberg Group, Boehringer Ingelheim +25 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Foresight Regulatory Strategy employee's phone or email?
The Foresight Regulatory Strategy annual revenue was $4 million in 2026.
Foresight Regulatory Strategy is based in Wilmington, Massachusetts.
The NAICS codes for Foresight Regulatory Strategy are [32541, 325, 32, 3254].
The SIC codes for Foresight Regulatory Strategy are [283, 28].